Search Within

Graduate Medical Education

Formats
  1. Meeting Abstract (1774)
  2. Journal Article (1684)
  3. Review (346)
  4. Editorial (161)
  5. Research Letter (82)
  6. Correspondence (61)
  7. Book Section (46)
  8. Miscellaneous (42)
  9. Conference Paper (19)
  10. Guidelines (4)
Groups
  1. Department of Medicine (2049)
  2. Sloan Kettering Institute Postdocs (1650)
  3. GME, Medicine (1560)
  4. Surgery (1398)
  5. Solid Tumor Oncology Division (1293)
  6. Survivorship Research (1147)

More Groups

People
  1. Nadeem Abu-Rustum (211)
  2. Britta Weigelt (170)
  3. Michael Scordo (159)
  4. Gunjan Shah (149)
  5. Kylee Maclachlan (144)
  6. Sergio Giralt (140)

More People

Years
  1. 2025 (327)
  2. 2024 (900)
  3. 2023 (912)
  4. 2022 (957)
  5. 2021 (486)
  6. 2020 (257)

More Years

Publications
  1. Journal of Clinical Oncology (364)
  2. Blood (307)
  3. International Journal of Radiation Oncology, Biology, Physics (201)
  4. Annals of Surgical Oncology (181)
  5. Gynecologic Oncology (165)
  6. Laboratory Investigation (104)

More Publications

Publishers
  1. Elsevier Inc. (798)
  2. American Society of Clinical Oncology (428)
  3. American Society of Hematology (350)
  4. Springer (321)
  5. Nature Publishing Group (260)
  6. Lippincott Williams & Wilkins (212)

More Publishers

Results (4219)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Meeting Abstract

    Kemeny, N. E.; Schwartz, L. H.; Gonen, M.; Yopp, A. C.; D'Angelica, M. I.; Fong, Y.; Haviland, D.; Gewirtz, A. N.; Allen, P. J.; Jarnagin, W. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The central nervous system is a target organ of acute graft-versus-host disease
    Meeting Abstract

    Hartrampf, S.; Dudakov, J. A.; Johnson, L. K.; Smith, O. M.; Tsai, J. J.; Hanash, A. M.; Singer, N. V.; West, M. L.; Liu, B. F.; Toth, M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Nrf2 regulates alloreactive T cell function during GVHD
    Meeting Abstract

    Tsai, J. J.; Tran, H.; Smith, O. M.; Yim, N.; Rao, U.; Takahashi, K.; Ghosh, A.; Na, I. K.; Jenq, R.; Hanash, A.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Journal Article

    Kemeny, N. E.; Schwartz, L.; Gonen, M.; Yopp, A.; Gultekin, D.; D'Angelica, M. I.; Fong, Y. M.; Haviland, D.; Gewirtz, A. N.; Allen, P.; more...
    Oncology (2011)

    Fulltext@MSK | Save
  • Genetically engineered donor T cells for BMT immunotherapy: Expression of trail and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer
    Journal Article

    Kemeny, N. E.; Jarnagin, W. R.; Capanu, M.; Fong, Y.; Gewirtz, A. N.; DeMatteo, R. P.; D'Angelica, M. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TRAIL/DR5 interactions are important for mediating thymic damage after allogeneic bone marrow transplantation
    Meeting Abstract

    Lu, S. X.; Na, I. K.; Yim, N.; Goldberg, G. L.; Tsai, J.; Rao, U. K.; Smith, M.; King, C. G.; Suh, D.; Hirschorn-Cymerman, D.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Over-expression of trail on donor T cells simultaneously ameliorates GVHD and enhances GVT
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Kappel, L. W.; Dogan, Y.; Yim, N.; Rao, U.; Smith, O. M.; Jenq, R. R.; Zakrzewski, J.; Na, I. K.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save